搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
来自MSN
2 天
FuelCell is Trading Below 50 and 200 Day SMA: How to Play the Stock?
FuelCell Energy FCEL is trading below its 50-day and 200-day simple moving average (SMA), signaling a bearish trend. FCEL ...
2 天
EUR/USD Forecast: Euro sellers retain control ahead of key inflation data
In case EUR/USD drops below 1.0380-1.0390 (200-period SMA on the 4-hour chart, Fibonacci 50% retracement of the latest ...
2 天
Cameco: Stay Away From This Uranium Play (Technical Analysis)
Cameco's most recent earnings results were mixed as revenue growth was at average levels while EPS dropped to near three-year ...
3 天
ECB Delivers Another 25 bp Cut
The ECB (European Central Bank) continued policy normalisation today, with another 25 basis points (bps) worth of cuts across ...
3 天
Germany approves weapons worth about $2.6 billion, Bloomberg News reports
German lawmakers have approved weapons and equipment orders worth about 2.5 billion euros ($2.6 billion) for the armed forces ...
4 天
EUR/USD Analysis Today 29/01: Renewed Pressure (Chart)
Ahead of the most important event for the Forex markets, the US federal Reserve announcement later today, the EUR/USD currency pair is resuming its broader downward trajectory, stabilizing around the ...
SMA
4 天
Levodopa therapy could ease SMA symptoms, per new mouse study
Problems with chemical messengers like dopamine were tied to posture issues in SMA in a mouse study, but levodopa therapy may ease symptoms.
forexcrunch
6 天
EUR/USD Outlook: Investors Brace for ECB, Fed Policy Decisions
The EUR/USD outlook suggests caution ahead of monetary policy meetings in the US and the Eurozone. Meanwhile, the pair has ...
forexcrunch
8 天
EUR/USD Weekly Forecast: Upbeat Data Relieves ECB Cut Odds
The EUR/USD weekly forecast suggests a rebound in the Eurozone economy, reducing ECB rate cut expectations. Due to upbeat ...
GlobalData on MSN
10 天
Biogen’s higher dose Spinraza under review by US and EU regulators
Biogen’s applications for the higher dose regimen of SMA drug Spinraza are now under review in the US and Europe.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈